• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2021 National Institute for Health and Care Excellence (NICE) Belimumab for treating active autoantibody-positive systemic lupus erythematosus. NICE technology appraisal guidance 752
2021 National Institute for Health and Care Excellence (NICE) Cenobamate for treating focal onset seizures in epilepsy. NICE technology appraisal guidance 753
2021 National Institute for Health and Care Excellence (NICE) Mogamulizumab for previously treated mycosis fungoides and Sezary syndrome. NICE technology appraisal guidance 754
2021 National Institute for Health and Care Excellence (NICE) Risdiplam for treating spinal muscular atrophy. NICE technology appraisal guidance 755
2021 National Institute for Health and Care Excellence (NICE) Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosis. NICE technology appraisal guidance 756
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Prostate cancer; does the use of fusion biopsy lead to better treatment results compared to the use of conventional diagnostic procedures?]
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pain in endometriosis: do other procedures instead of painkillers also help?]
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Multiple sclerosis: does the use of mHealth solutions (e.g. apps) lead to better results in the self-management of those affected?]
2021 Gesundheit Osterreich GmbH (GOeG) [Quick assessment on the use of fluoride in caries prophylaxis in children, adolescents and pregnant women]
2021 Gesundheit Osterreich GmbH (GOeG) [Concepts, indicators and measurement instruments for recording the impact of anti-stigma measures in mental health - quick assessment]
2021 National Institute for Health and Care Excellence (NICE) Transanal total mesorectal excision for rectal cancer. NICE interventional procedures guidance 713
2021 National Institute for Health and Care Excellence (NICE) Endobronchial nerve ablation for chronic obstructive pulmonary disease. NICE interventional procedures guidance 714
2021 National Institute for Health and Care Excellence (NICE) Percutaneous implantation of pulmonary artery pressure sensors for monitoring treatment of chronic heart failure. NICE interventional procedures guidance 711
2021 National Institute for Health and Care Excellence (NICE) Coronary sinus narrowing device implantation for refractory angina. NICE interventional procedures guidance 712
2021 National Institute for Health and Care Excellence (NICE) Genicular artery embolisation for pain from knee osteoarthritis. NICE interventional procedures guidance 708
2021 National Institute for Health and Care Excellence (NICE) Laparoscopic renal denervation for loin pain haematuria syndrome. NICE interventional procedures guidance 709
2021 National Institute for Health and Care Excellence (NICE) Percutaneous endovascular forearm arteriovenous fistula creation for haemodialysis access. NICE interventional procedures guidance 710
2021 National Institute for Health and Care Excellence (NICE) Lateral elbow resurfacing for arthritis. NICE interventional procedures guidance 705
2021 National Institute for Health and Care Excellence (NICE) Transapical transcatheter mitral valve-in-valve implantation for a failed surgically implanted mitral valve bioprosthesis. NICE interventional procedures guidance 706
2021 National Institute for Health and Care Excellence (NICE) Transapical transcatheter mitral valve-in-ring implantation after failed annuloplasty for mitral valve repair. NICE interventional procedures guidance 707
2021 National Institute for Health and Care Excellence (NICE) Magnetic resonance therapy for knee osteoarthritis. NICE interventional procedures guidance 702
2021 National Institute for Health and Care Excellence (NICE) Laparoscopic removal of uterine fibroids with power morcellation. NICE interventional procedures guidance 703
2021 National Institute for Health and Care Excellence (NICE) Hysteroscopic mechanical tissue removal (hysteroscopic morcellation) for uterine fibroids. NICE interventional procedures guidance 704
2021 National Institute for Health and Care Excellence (NICE) Inducing and maintaining normothermia using temperature modulation devices to improve outcomes after stroke or subarachnoid haemorrhage. NICE interventional procedures guidance 701
2021 National Institute for Health and Care Excellence (NICE) Laser lithotripsy for difficult-to-treat bile duct stones. NICE interventional procedures guidance 699
2021 National Institute for Health and Care Excellence (NICE) Percutaneous insertion of a closure device to repair a paravalvular leak around a replaced mitral or aortic valve. NICE interventional procedures guidance 700
2021 National Institute for Health and Care Excellence (NICE) Electrohydraulic lithotripsy for difficult-to-treat bile duct stones. NICE interventional procedures guidance 698
2021 National Institute for Health and Care Excellence (NICE) Ex-situ machine perfusion for extracorporeal preservation of lungs (ex-vivo lung perfusion) for transplant. NICE interventional procedures guidance 695
2021 National Institute for Health and Care Excellence (NICE) Transvaginal laser therapy for stress urinary incontinence. NICE interventional procedures guidance 696
2021 National Institute for Health and Care Excellence (NICE) Transvaginal laser therapy for urogenital atrophy. NICE interventional procedures guidance 697
2021 National Institute for Health and Care Excellence (NICE) Permanent His-bundle pacemaker implantation for treating heart failure. NICE interventional procedures guidance 694
2021 National Institute for Health and Care Excellence (NICE) Repetitive short-pulse transscleral cyclophotocoagulation for glaucoma. NICE interventional procedures guidance 692
2021 National Institute for Health and Care Excellence (NICE) Deep brain stimulation for chronic, severe, treatment-resistant obsessive-compulsive disorder in adults. NICE interventional procedures guidance 693
2021 National Institute for Health and Care Excellence (NICE) Melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liver. NICE interventional procedures guidance 691
2021 National Institute for Health and Care Excellence (NICE) Transcervical ultrasound-guided radiofrequency ablation for symptomatic uterine fibroids. NICE interventional procedures guidance 689
2021 National Institute for Health and Care Excellence (NICE) Extracorporeal whole liver perfusion for acute liver failure. NICE interventional procedures guidance 690
2021 National Institute for Health and Care Excellence (NICE) Free-functioning gracilis transfer to restore upper limb function in brachial plexus injury. NICE interventional procedures guidance 687
2021 National Institute for Health and Care Excellence (NICE) Cytoreduction surgery with hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis. NICE interventional procedures guidance 688
2021 National Institute for Health and Care Excellence (NICE) Self-expanding implant insertion into the intersphincteric space for faecal incontinence. NICE interventional procedures guidance 685
2021 National Institute for Health and Care Excellence (NICE) Minimally invasive radical hysterectomy for early stage cervical cancer. NICE interventional procedures guidance 686
2021 HTA South [Circadian rhythm lighting in psychiatry, care of the elderly and dementia, and rehabilitation]
2021 National Institute for Health and Care Excellence (NICE) Endo-SPONGE for treating low rectal anastomotic leak. NICE medical technologies guidance 63
2021 National Institute for Health and Care Excellence (NICE) ClearGuard HD antimicrobial barrier caps for preventing haemodialysis catheter-related bloodstream infections. NICE medical technologies guidance 62
2021 National Institute for Health and Care Excellence (NICE) Synergo for non-muscle-invasive bladder cancer. NICE medical technologies guidance 61
2021 National Institute for Health and Care Excellence (NICE) DyeVert Systems for reducing the risk of acute kidney injury in coronary and peripheral angiography. NICE medical technologies guidance 60
2021 National Institute for Health and Care Excellence (NICE) Plus Sutures for preventing surgical site infection. NICE medical technologies guidance 59
2021 National Institute for Health and Care Excellence (NICE) UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia. NICE medical technologies guidance 58
2021 National Institute for Health and Care Excellence (NICE) Danis stent for acute oesophageal variceal bleeding. NICE medical technologies guidance 57
2021 National Institute for Health and Care Excellence (NICE) Alpha-Stim AID for anxiety disorders. NICE medical technologies guidance 56
2021 National Institute for Health and Care Excellence (NICE) Leukomed Sorbact for preventing surgical site infection. NICE medical technologies guidance 55
2021 National Institute for Health and Care Excellence (NICE) The VAC Veraflo Therapy system for acute infected or chronic wounds that are failing to heal. NICE medical technologies guidance 54
2021 National Institute for Health and Care Excellence (NICE) The PLASMA system for transurethral resection and haemostasis of the prostate. NICE medical technologies guidance 53
2021 National Institute for Health and Care Excellence (NICE) SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoea. NICE diagnostics guidance 44
2021 National Institute for Health and Care Excellence (NICE) QAngio XA 3D QFR and CAAS vFFR imaging software for assessing coronary stenosis during invasive coronary angiography. NICE diagnostics guidance 43
2021 Canary Health Service [Molecular markers for the detection of clinically significant prostate cancer]
2021 Health Information and Quality Authority (HIQA) The identification and review of new and updated public health guidance - COVID-19
2021 Health Information and Quality Authority (HIQA) Duration of protective immunity following COVID-19 vaccination (efficacy and effectiveness)
2021 Health Information and Quality Authority (HIQA) An international review: Policies relating to healthcare personnel who do not avail of COVID-19 vaccination
2021 Health Information and Quality Authority (HIQA) Evidence synthesis for groups in vaccine allocation group nine - those aged 18-64 years living or working in crowded conditions
2021 Health Information and Quality Authority (HIQA) Advice to the National Public Health Emergency Team: Derogation of healthcare workers, who are deemed close contacts, from restricted movements following COVID-19 vaccination
2021 Health Information and Quality Authority (HIQA) Public health measures and strategies to limit the spread of COVID-19: an international review [Update]
2021 Health Information and Quality Authority (HIQA) Public health measures and strategies to limit the spread of COVID-19: an international review: Antigen testing in asymptomatic individuals in community settings
2021 Health Information and Quality Authority (HIQA) Current public health guidance for community settings and infection prevention and control measures in healthcare settings for COVID-19: a rapid review
2021 Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Analysis of the volume-outcome relationship in digestive cancer surgery]
2021 Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Femtosecond laser-assisted cataract surgery (FLACS). Effectiveness, security and efficiency assessment]
2021 Health Information and Quality Authority (HIQA) Systematic review of cost-effectiveness – management of chronic obstructive pulmonary disease in adults
2021 Health Information and Quality Authority (HIQA) Budget impact analysis – management of chronic obstructive pulmonary disease in adults
2021 Health Information and Quality Authority (HIQA) Budget impact analysis – National Clinical Guideline. Unexpected intraoperative life threatening haemorrhage guideline
2021 Health Information and Quality Authority (HIQA) Budget impact analysis – stop smoking
2020 Haute Autorite de sante (HAS) [New bariatric surgery techniques: identification, progress report and assessment opportunities]
2020 NIHR Health Technology Assessment programme Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT
2020 Institut national d'excellence en sante et en services sociaux (INESSS) [Portrait of coronary revascularization by percutaneous coronary intervention and coronary bypass grafting in Quebec, 2015-2018]
2020 NIHR Health Technology Assessment programme Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT
2020 NIHR Health Technology Assessment programme Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial
2020 NIHR Health Technology Assessment programme Best-practice prevention alone or with conventional or biological caries management for 3- to 7-year-olds: the FiCTION three-arm RCT
2020 NIHR Health Technology Assessment programme Total versus partial knee replacement in patients with medial compartment knee osteoarthritis: the TOPKAT RCT
2020 NIHR Health Technology Assessment programme High-dose oral vitamin D supplementation and mortality in people aged 65 84 years: the VIDAL cluster feasibility RCT of open versus double-blind individual randomisation
2020 NIHR Health Technology Assessment programme An extended stroke rehabilitation service for people who have had a stroke: the EXTRAS RCT
2020 NIHR Health Technology Assessment programme Risk-based, 6-monthly and 24-monthly dental check-ups for adults: the INTERVAL three-arm RCT
2020 NIHR Health Technology Assessment programme Sodium bicarbonate to improve physical function in patients over 60 years with advanced chronic kidney disease: the BiCARB RCT
2020 NIHR Health Technology Assessment programme Two speeds of increasing milk feeds for very preterm or very low-birthweight infants: the SIFT RCT
2020 NIHR Health Technology Assessment programme Basic versus biofeedback-mediated intensive pelvic floor muscle training for women with urinary incontinence: the OPAL RCT
2020 NIHR Health Technology Assessment programme Dementia Care Mapping to reduce agitation in care home residents with dementia: the EPIC cluster RCT
2020 NIHR Health Technology Assessment programme Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT
2020 NIHR Health Technology Assessment programme Surgical fixation compared with cast immobilisation for adults with a bicortical fracture of the scaphoid waist: the SWIFFT RCT
2020 NIHR Health Technology Assessment programme Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT
2020 NIHR Health Technology Assessment programme Thoracoscopy and talc poudrage compared with intercostal drainage and talc slurry infusion to manage malignant pleural effusion: the TAPPS RCT
2020 NIHR Health Technology Assessment programme Silver-impregnated, antibiotic-impregnated or non-impregnated ventriculoperitoneal shunts to prevent shunt infection: the BASICS three-arm RCT
2020 NIHR Health Technology Assessment programme Surgical interventions for uterine prolapse and for vault prolapse: the two VUE RCTs
2020 NIHR Health Technology Assessment programme Open urethroplasty versus endoscopic urethrotomy for recurrent urethral stricture in men: the OPEN RCT
2020 NIHR Health Technology Assessment programme Robot-assisted training compared with an enhanced upper limb therapy programme and with usual care for upper limb functional limitation after stroke: the RATULS three-group RCT
2020 NIHR Health Technology Assessment programme Computerised speech and language therapy or attention control added to usual care for people with long-term post-stroke aphasia: the Big CACTUS three-arm RCT
2020 NIHR Health Technology Assessment programme Urodynamics tests for the diagnosis and management of bladder outlet obstruction in men: the UPSTREAM non-inferiority RCT
2020 NIHR Health Technology Assessment programme Seizure first aid training for people with epilepsy attending emergency departments and their significant others: the SAFE intervention and feasibility RCT
2020 NIHR Health Technology Assessment programme Unspecified living kidney donation in the UK: barriers to implementation and delivery
2020 NIHR Health Technology Assessment programme Understanding the health-care experiences of people with sickle cell disorder transitioning from paediatric to adult services: This Sickle Cell Life, a longitudinal qualitative study
2020 NIHR Health Technology Assessment programme An app-, web- and social support-based weight loss intervention for adults with obesity: the HelpMeDoIt! feasibility RCT
2020 NIHR Health Technology Assessment programme Gabapentin to reduce pain in women aged between 18 and 50 years with chronic pelvic pain: the GaPP2 RCT
2020 NIHR Health Technology Assessment programme Ursodeoxycholic acid to reduce adverse perinatal outcomes for intrahepatic cholestasis of pregnancy: the PITCHES RCT
2020 NIHR Health Technology Assessment programme Adding web-based behavioural support to exercise referral schemes for inactive adults with chronic health conditions: the e-coachER RCT